上海红星美凯龙品牌管理有限公司海安分公司
公司优势
20,861+ 岗位更新等你来订阅
一键订阅最新的岗位，每周送达
🎉恭喜你，订阅成功
继续订阅您可以在邮箱中随时取消订阅
上海万街商业经营管理有限公司（以下简称：万街商业）于2014年6月26日在上海股交中心成功挂牌上市，并在上海股权交易中心举办了隆重的挂牌仪式。
1号街是万街商业的核心业务，是一个颠覆传统商业地产模式的新型商业地产品牌。其创立的宗旨是：以社区O2O模式为基础，以消费者体验式服务为核心，致力于解决社区服务最后一公里难题，发展平衡商业圈，营造1号街的利益共同体。目前，1号街已成功实施了56个社区商业项目。
万街商业专注于为社区商业的业主提供优质的资产增值与变现业务，目前累计经营管理资产超过300亿元，管理面积已超过100万平方米。
万街商业秉承山文化，践行企业价值观“诚信感恩，求知务实，主动挑战，拥抱变化”，并成立了专业的社区商业黄埔军校——万街大学，为市场培育和孵化专业的社区商业运营专家。
万街商业坚信市场永远处于变化之中，主动迎接未来的挑战。在未来的道路上，一定需要更多优秀的人才共同前行，实现梦想！
Main business scope: repair services, general stores, engine spare parts
Our target is to provide professional, high quality and fast services to all ship owners
Professional, high quality, fast
Strive to provide employees with a stage for free development in their careers
Founded in 2008, the company's performance has been steadily growing at around 10% annually
Received consistent positive feedback from domestic and international shipowners
广一泵业有限公司，位于粤港澳大湾区核心城市中山市，创立于1958年，拥有超过60年的各类水泵生产经验，是一家专业从事水泵及整套供水设备制造的民营企业。公司于2019年在中山市黄圃镇马新工业园区启动新的总部生产基地建设项目，总投资1.4亿元，占地55亩，包括4000平方米的办公楼和36000平方米的厂房，并配备了员工宿舍和食堂。该基地已于2020年9月正式投入运营。
加入我们吧！广一泵业，一个致力于为你搭建成功平台的企业！在这里，你可以找到属于自己的舞台。
Vazyme - Innovation in Enzyme Technology
Founded in 2012 and located in the Nanjing High-tech Zone (stock code: 688105), Nanjing Vazyme Biotech Co., Ltd. is a biotechnology company focusing on the development of technological innovations and products related to enzymes, antigens, antibodies, and other functional proteins and high molecular organic materials. Leveraging its independently established key technology platform, the company has ventured into fields such as life sciences, in vitro diagnostics, and bio-pharmaceuticals. As one of the few companies in China with both upstream technology development capabilities and downstream product manufacturing capabilities, Vazyme aims to create "biochips" and continuously inject new vitality into the biotechnology industry.
Innovation and Talent Pool
Vazyme has always adhered to innovation and breakthroughs, insisting on developing from the source of technology. With its proprietary core technologies, it has built an independently controllable key technology platform that enables rapid, efficient, and large-scale product development. The company currently offers over 600 types of genetically engineered recombinant enzymes and more than 2,500 high-performance antigens and monoclonal antibodies, along with over 2,000 terminal products applicable to scientific research, high-throughput sequencing, in vitro diagnostics, pharmaceutical and vaccine development, and animal quarantine.
A strong R&D capability is supported by a robust talent pool. Vazyme boasts a team of nearly 700 R&D personnel, including experts in molecular biology, enzymology, immunology, bioinformatics, organic chemistry, and materials science. Over 67% of these R&D staff hold master’s degrees or higher.
Mastery of Core Raw Material Technologies and Downstream Industrial Advantages
Since its establishment, Vazyme has always adhered to a business philosophy centered around R&D, continuously upgrading its core technologies and expanding into new business areas. Through years of relentless efforts, Vazyme has achieved significant technical accomplishments in the fields of biology, healthcare, and pharmaceuticals. It has successfully launched various series of biological reagents, including high-throughput sequencing library construction, PCR, qPCR, molecular cloning, reverse transcription, and Bio-assay, as well as POCT diagnostic reagents covering nine categories such as cardiovascular diseases, inflammation, infections, reproductive health, gastric function, respiratory system, and nervous system. Its customer base includes research institutions, high-throughput sequencing service enterprises, molecular diagnostic reagent manufacturers, pharmaceutical companies, CROs, and hospitals.
Staying True to Our Mission and Fulfilling Responsibilities
While expanding its product and technology chains, Vazyme remains committed to its mission of "Technology for Healthier Lives," constantly developing new technologies, providing high-quality products, and professional services to contribute value to customers. Rooted in the principle of putting hardworking individuals first, Vazyme provides a broad development platform to attract outstanding talents from across the country and even the world, driving the overall development and enhancement of China's biotechnology and medical industries. Actively engaging in public health initiatives, Vazyme uses technology to support national biosafety efforts, helping humanity combat major infectious diseases, tumors, and autoimmune disorders!
建立于1828年的必维国际检验集团，作为全球领先的国际化检验与认证机构，专注于质量、健康、安全、环境管理和社会责任评估等多个领域。自成立以来，其服务网络遍布全球150多个国家，拥有超过900个办事处和实验室，庞大的员工团队约有40,000人，致力于为全球各地370,000个不同行业客户提供专业服务。在中国，必维集团拥有4,000名员工，运营着30个办公室和实验室，为超过30,000个客户提供了卓越的客户服务。作为业界翘楚，必维国际检验集团在全球范围内获得了众多国家政府及权威机构的高度认可。